Literature DB >> 109460

Thyrotropin secretion in patients with central hypothyroidism: evidence for reduced biological activity of immunoreactive thyrotropin.

G Faglia, L Bitensky, A Pinchera, C Ferrari, A Paracchi, P Beck-Peccoz, B Ambrosi, A Spada.   

Abstract

TSH concentration was measured in plasma before and after TRH administration (200 micrograms, iv) in 89 patients with documented hypothyroidism consequent to various hypothalamic-pituitary disorders. Basal plasma TSH was less than 1.0 microI/ml in 34.8%, between 1.0-3.6 microU/ml in 40.5% and slightly elevated (3.7-9.7 microU/ml) in 24.7% of the cases. The plasma TSH response to TRH was absent in 13.5%, impaired in 16.8%, normal in 47.2%, and exaggerated in 22.5% of the cases, with delayed and/or prolonged pattern of response in 65% of the cases. The dilution curves of several plasmas drawn before and after TRH were parallel to those obtained with TSH standard preparation. After gel filtration, the elution pattern of TRH-stimulated plasmas from 4 patients did not show any major difference from that of pooled plasmas from normal subjects given TRH or from that of patients with primary hypothyroidism. Plasma TSH values determined by cytochemical bioassay on both basal and TRH-stimulated samples of 5 patients were markedly lower than those obtained by RIA. The serum T3 response to TRH was absent or low in 40 out of 53 patients in whom it was evaluated. The administration of T3 (100 micrograms/day for 3 days) or dexamethasone (3 mg/day for 5 days) respectively suppressed or reduced both basal and TRH-induced plasma TSH levels. Two patients became hypothyroid shortly after pituitary surgery in spite of basal and TRH-induced plasma TSH levels similar to or higher than those before surgery. Though thyroid atrophy due to chronic understimulation could explain the low T3 response to TRH in secondary hypothyroidism, it is difficult to reconcile thyroid understimulation with normal or increased plasma TSH unless the immunoreactive material has low biological activity. Present data suggest that several patients with hypothyroidism consequent to hypothalamic-pituitary diseases secrete a material which is immunologically similar to pituitary standard TSH and responds to stimulatory and suppressive agents in a manner similar to normal TSH but has low or absent biological activity. Thus, hypothyroidism due to insufficient TSH stimulation can be termed central hypothyroidism and can be due 1) to pituitary insufficiency (secondary hypothyroidism), 2) to a hypothalamic defect (tertiary hypothyroidism), or 3) to the secretion of biologically inactive TSH.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 109460     DOI: 10.1210/jcem-48-6-989

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  33 in total

1.  Case 2: Hypoglycemia and micropenis in the newborn - hormonal red flags.

Authors:  Stacey Urbach; Clodagh O'Gorman; Dalia Alabdulrazzaq
Journal:  Paediatr Child Health       Date:  2009-09       Impact factor: 2.253

Review 2.  Thyrotropin isoforms: implications for thyrotropin analysis and clinical practice.

Authors:  Joshua M Estrada; Danielle Soldin; Timothy M Buckey; Kenneth D Burman; Offie P Soldin
Journal:  Thyroid       Date:  2013-12-13       Impact factor: 6.568

3.  Target Gland Dysfunction Following External Cranial Radiation for Extrasellar Tumours.

Authors:  M K Garg
Journal:  Med J Armed Forces India       Date:  2011-07-21

4.  Normal thyroxine and elevated thyrotropin concentrations: evolving hypothyroidism or persistent euthyroidism with reset thyrostat.

Authors:  U M Kabadi; R Cech
Journal:  J Endocrinol Invest       Date:  1997-06       Impact factor: 4.256

5.  Adenohypophyseal hormone levels in the cerebrospinal fluid of patients with pituitary disease.

Authors:  L Dogliotti; R Faggiuolo; F Orlandi; P Paccotti; A Angeli
Journal:  J Endocrinol Invest       Date:  1983-12       Impact factor: 4.256

6.  TSH secretion in thalassemia.

Authors:  I M Spitz; H J Hirsch; H Landau; E Zylber-Haran; V Gross; E A Rachmilewitz
Journal:  J Endocrinol Invest       Date:  1984-10       Impact factor: 4.256

7.  Pituitary and hypothalamic dysfunction in a patient with a basal encephalocele.

Authors:  J D Booth; R G Josse; W Singer
Journal:  J Endocrinol Invest       Date:  1983-12       Impact factor: 4.256

8.  Exaggerated and prolonged thyrotrophin releasing hormone (TRH) test responses in tertiary hypothyroidism.

Authors:  G H Mills; R D Ellis; P R Beck
Journal:  J Clin Pathol       Date:  1991-06       Impact factor: 3.411

9.  Abnormal thyroid stimulating hormone following pituitary surgery.

Authors:  G K Worth; R W Retallack; D H Gutteridge
Journal:  J Endocrinol Invest       Date:  1981 Apr-Jun       Impact factor: 4.256

10.  Hypothalamic-pituitary-thyroid axis in acromegaly.

Authors:  E Carmina; F Rosato; S Pirronello; A Jannì
Journal:  J Endocrinol Invest       Date:  1983-08       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.